Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Immunol Allergy Clin North Am. 2014 Aug 29;34(4):809–823. doi: 10.1016/j.iac.2014.07.006

Figure 1.

Figure 1

Potential therapeutics for obese, adult asthmatics described in this review modulate pathways common to several metabolic and nutritional disorders. This allows for the treatment of several comorbidities by targeting their common dysfunction as opposed to individual symptoms. Direct targets include AMPK, which regulates numerous cellular metabolic pathways involved in energy storage and NOS3, which modulates vascular and bronchial smooth muscle tone.